Limitation of Acinetobacter baumannii treatment by plasmid-mediated carbapenemase ARI-2
- 1 January 1998
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 351 (9097) , 186-187
- https://doi.org/10.1016/s0140-6736(05)78210-6
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibilityJournal of Antimicrobial Chemotherapy, 1997
- Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methodsJournal of Clinical Microbiology, 1994
- ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumanniiInternational Journal of Antimicrobial Agents, 1993
- 1.1 IntroductionJournal of Antimicrobial Chemotherapy, 1991